BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 16283295)

  • 1. Aptamers--basic research, drug development, and clinical applications.
    Proske D; Blank M; Buhmann R; Resch A
    Appl Microbiol Biotechnol; 2005 Dec; 69(4):367-74. PubMed ID: 16283295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aptamers: from bench side research towards patented molecules with therapeutic applications.
    Majumder P; Gomes KN; Ulrich H
    Expert Opin Ther Pat; 2009 Nov; 19(11):1603-13. PubMed ID: 19852719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of DNA aptamers against VEGF165 using a protein competitor and the aptamer blotting method.
    Hasegawa H; Sode K; Ikebukuro K
    Biotechnol Lett; 2008 May; 30(5):829-34. PubMed ID: 18175068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development and testing of aptamers for cancer.
    Barbas AS; White RR
    Curr Opin Investig Drugs; 2009 Jun; 10(6):572-8. PubMed ID: 19513946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection and characterization of DNA aptamers against VEGF165 with aptamer blotting method and its application.
    Ikebukuro K; Hasegawa H; Sode K
    Nucleic Acids Symp Ser (Oxf); 2007; (51):399-400. PubMed ID: 18029755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aptamers come of age - at last.
    Bunka DH; Stockley PG
    Nat Rev Microbiol; 2006 Aug; 4(8):588-96. PubMed ID: 16845429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chemical biology of aptamers.
    Mayer G
    Angew Chem Int Ed Engl; 2009; 48(15):2672-89. PubMed ID: 19319884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineered 5S ribosomal RNAs displaying aptamers recognizing vascular endothelial growth factor and malachite green.
    Zhang X; Potty AS; Jackson GW; Stepanov V; Tang A; Liu Y; Kourentzi K; Strych U; Fox GE; Willson RC
    J Mol Recognit; 2009; 22(2):154-61. PubMed ID: 19195013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aptamer therapeutics advance.
    Lee JF; Stovall GM; Ellington AD
    Curr Opin Chem Biol; 2006 Jun; 10(3):282-9. PubMed ID: 16621675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanotechnology and aptamers: applications in drug delivery.
    Levy-Nissenbaum E; Radovic-Moreno AF; Wang AZ; Langer R; Farokhzad OC
    Trends Biotechnol; 2008 Aug; 26(8):442-9. PubMed ID: 18571753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aptamers against extracellular targets for in vivo applications.
    Pestourie C; Tavitian B; Duconge F
    Biochimie; 2005; 87(9-10):921-30. PubMed ID: 15963620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex target SELEX.
    Shamah SM; Healy JM; Cload ST
    Acc Chem Res; 2008 Jan; 41(1):130-8. PubMed ID: 18193823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aptamers: the emerging class of future anticoagulation for vascular disease.
    Kuliczkowski W; Floyd J; Malinin A; Serebruany V
    Expert Rev Cardiovasc Ther; 2010 Apr; 8(4):503-7. PubMed ID: 20397824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy progress and prospects: RNA aptamers.
    Que-Gewirth NS; Sullenger BA
    Gene Ther; 2007 Feb; 14(4):283-91. PubMed ID: 17279100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The future of aptamers in medicine.
    Khati M
    J Clin Pathol; 2010 Jun; 63(6):480-7. PubMed ID: 20360137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aptamers-based assays for diagnostics, environmental and food analysis.
    Tombelli S; Minunni M; Mascini M
    Biomol Eng; 2007 Jun; 24(2):191-200. PubMed ID: 17434340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in SELEX and application of aptamers in the central nervous system.
    Yang Y; Yang D; Schluesener HJ; Zhang Z
    Biomol Eng; 2007 Dec; 24(6):583-92. PubMed ID: 17681489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locked nucleic acid nucleoside triphosphates and polymerases: on the way towards evolution of LNA aptamers.
    Veedu RN; Wengel J
    Mol Biosyst; 2009 Aug; 5(8):787-92. PubMed ID: 19603111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands.
    Stoltenburg R; Reinemann C; Strehlitz B
    Biomol Eng; 2007 Oct; 24(4):381-403. PubMed ID: 17627883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aptamers as tools for target validation.
    Blank M; Blind M
    Curr Opin Chem Biol; 2005 Aug; 9(4):336-42. PubMed ID: 16006181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.